Main content

 DiagnoSwiss (DS)

 

ds

Further Information : http://www.diagnoswiss.com/

 

General Description

DiagnoSwiss (DS) is an SME specialised in the development and commercialisation of micro fluidic platforms for electrochemical detection. These platforms rely on microchips with microstructures that have been specifically designed to have a reactor for all step-limiting reactions to obtain a rapid and sensitive detection of proteins in different matrices. This technology combines proprietary micro fluidic sensors with magnetic nanoparticles and automation into a broad biosensor platform for fast biochemical analysis. It is more particularly developed for semi-automated micro-ELISAs.

DS R&D activities are focused on the development of analytical tools and methods for protein analysis. Recently integrated within Mondema, a Swiss company specialised in automation, fluid handling, mechanics, electrotechnics, and computing, DS now further offers design, engineering, industrialisation and production of customized products according to ISO13485 certification. Current research includes immunoassays in electrochemical microchips combining magnetic nanoparticles and automation. Beside the design & fabrication of novel polymer microchips with integrated electrodes, DS thus concentrates its R&D efforts on the development of new electrochemical detection methods, of innovative immunoassay analysers and on the adaptation and optimisation of bead-based assays in microchips with electrochemical detection.

Key Personel

Priscille Giron, M.Sc., PhD completed her Licence in Biology and Biochemistry at the Université Louis Pasteur (Strasbourg I). She continued her graduate education with dual Master's degrees in Biochemistry (Université Louis Pasteur, Strasbourg I) and Proteomics (Université des Sciences et Technologies de Lille, Lille I), followed by a Master's internship at INSERM. She completed her PhD in Proteomics and Chemistry at the University of Geneva. As a Post-Doctoral Fellow / Research Associate she completed her training at the University of Applied Sciences Western Switzerland, HES-SO/ SCAHT. She has been qualified by the Swiss Federal Institute of Technology of Lausanne (EPFL) in the Management of Biotech, Medtech and Pharma Ventures. Dr Giron is R&D Manager at DiagnoSwiss.